marketcaparena
Search

    MMSI

    MERIT MEDICAL SYSTEMS INC

    Company overview

    Market capitalization
    $5.19B
    Employees
    7,500
    Latest publication
    2026-09-29
    About MERIT MEDICAL SYSTEMS INC

    Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue418,843,000USD382,394,000USD394,184,000USD384,263,000USD381,953,000USD354,330,000USD355,158,000USD339,845,000USD
    Cost Of Revenue203,677,000USD197,995,000USD198,735,000USD197,746,000USD197,733,000USD182,799,000USD182,175,000USD182,310,000USD
    Gross Profit215,166,000USD184,399,000USD195,449,000USD186,517,000USD184,220,000USD171,531,000USD172,983,000USD157,535,000USD
    Research Development25,389,000USD22,609,000USD26,541,000USD23,966,000USD24,367,000USD22,478,000USD25,194,000USD20,527,000USD
    Selling General Administrative129,229,000USD118,210,000USD114,830,000USD119,801,000USD113,097,000USD107,486,000USD111,074,000USD99,644,000USD
    Total Operating Expenses154,763,000USD140,819,000USD141,371,000USD143,767,000USD137,464,000USD120,764,000USD136,419,000USD120,274,000USD
    Operating Income60,403,000USD43,580,000USD54,078,000USD42,750,000USD46,756,000USD50,767,000USD36,564,000USD37,261,000USD
    Total Other Income Expense Net-9,089,000USD9,966,000USD-3,018,000USD-4,210,000USD-3,377,000USD-12,809,000USD-3,419,000USD-604,000USD
    Interest Expense12,118,000USD6,526,000USD6,364,000USD6,754,000USD6,775,000USD6,568,000USD7,993,000USD7,501,000USD
    Income Before Tax51,314,000USD53,546,000USD51,060,000USD38,540,000USD43,379,000USD37,958,000USD33,145,000USD36,657,000USD
    Income Tax Expense12,511,000USD12,551,000USD13,054,000USD10,785,000USD10,798,000USD7,811,000USD5,198,000USD8,213,000USD
    Net Income38,803,000USD40,995,000USD38,006,000USD27,755,000USD32,581,000USD30,147,000USD27,947,000USD28,444,000USD
    Interest Income—3,900,000USD3,904,000USD3,615,000USD3,761,000USD3,790,000USD4,741,000USD6,652,000USD
    Net Interest Income—-2,626,000USD-2,460,000USD-3,139,000USD-3,014,000USD-2,778,000USD-3,252,000USD-849,000USD
    Tax Provision—12,551,000USD13,054,000USD10,785,000USD10,798,000USD7,811,000USD5,198,000USD8,213,000USD
    Net Income From Continuing Ops—40,995,000USD38,006,000USD27,755,000USD32,581,000USD30,147,000USD27,947,000USD28,444,000USD
    Ebit—60,072,000USD57,424,000USD45,294,000USD50,154,000USD44,526,000USD41,138,000USD44,413,000USD
    Ebitda—93,422,000USD91,751,000USD79,537,000USD83,957,000USD76,802,000USD72,734,000USD73,796,000USD
    Depreciation And Amortization—33,350,000USD34,327,000USD34,243,000USD33,803,000USD32,276,000USD31,596,000USD29,383,000USD
    Reconciled Depreciation—33,350,000USD34,327,000USD34,243,000USD33,803,000USD32,276,000USD31,596,000USD29,383,000USD
    Unclassified Operating Expenses—————-9,200,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,514,730,000USD1,356,514,000USD1,257,366,000USD1,150,981,000USD1,074,751,000USD963,875,000USD994,852,000USD882,753,000USD
    Cost Of Revenue777,787,000USD713,181,000USD673,494,000USD631,882,000USD589,418,000USD562,698,000USD562,486,000USD487,983,000USD
    Gross Profit736,943,000USD643,333,000USD583,872,000USD519,099,000USD485,333,000USD401,177,000USD432,366,000USD394,770,000USD
    Research Development97,352,000USD83,812,000USD82,728,000USD75,510,000USD71,247,000USD57,537,000USD65,615,000USD59,532,000USD
    Selling General Administrative455,214,000USD399,731,000USD361,168,000USD342,525,000USD335,690,000USD297,724,000USD327,274,000USD276,018,000USD
    Total Operating Expenses552,566,000USD487,640,000USD458,728,000USD431,536,000USD424,417,000USD402,739,000USD416,932,000USD335,550,000USD
    Operating Income184,377,000USD155,693,000USD123,944,000USD87,563,000USD60,916,000USD-1,562,000USD15,434,000USD58,617,000USD
    Interest Income15,070,000USD26,230,000USD656,000USD439,000USD769,000USD604,000USD291,000USD1,199,000USD
    Interest Expense26,461,000USD31,219,000USD15,511,000USD6,339,000USD5,261,000USD9,994,000USD12,704,000USD10,360,000USD
    Net Interest Income-11,391,000USD-4,989,000USD-12,037,000USD-5,900,000USD-4,492,000USD-9,390,000USD-12,704,000USD-9,161,000USD
    Income Before Tax170,937,000USD149,993,000USD112,089,000USD82,629,000USD53,917,000USD-13,231,000USD2,193,000USD49,519,000USD
    Income Tax Expense42,448,000USD29,636,000USD17,678,000USD8,113,000USD5,463,000USD-3,388,000USD-3,258,000USD7,502,000USD
    Tax Provision42,448,000USD29,636,000USD10,594,000USD8,113,000USD5,463,000USD-3,388,000USD-3,258,000USD7,502,000USD
    Net Income128,489,000USD120,357,000USD94,411,000USD74,516,000USD48,454,000USD-9,843,000USD5,451,000USD42,017,000USD
    Net Income From Continuing Ops128,489,000USD120,357,000USD100,183,000USD74,516,000USD48,454,000USD-9,843,000USD5,451,000USD42,017,000USD
    Ebit197,398,000USD159,236,000USD127,600,000USD88,968,000USD59,178,000USD-3,237,000USD14,897,000USD59,879,000USD
    Ebitda332,047,000USD273,968,000USD228,892,000USD181,166,000USD154,962,000USD103,579,000USD119,253,000USD129,425,000USD
    Depreciation And Amortization134,649,000USD114,732,000USD101,292,000USD92,198,000USD95,784,000USD106,816,000USD104,356,000USD69,546,000USD
    Reconciled Depreciation134,649,000USD114,732,000USD98,047,000USD92,198,000USD95,784,000USD106,816,000USD104,356,000USD69,546,000USD
    Total Other Income Expense Net-13,440,000USD-5,700,000USD-11,855,000USD-4,934,000USD-6,999,000USD-11,669,000USD-13,241,000USD-9,098,000USD
    Unclassified Operating Expenses——14,832,000USD13,501,000USD17,480,000USD47,478,000USD24,043,000USD—
    Non Operating Income Net Other———1,405,000USD-1,738,000USD-1,675,000USD—1,262,000USD
    Net Income Applicable To Common Shares———74,516,000USD48,454,000USD-9,843,000USD5,451,000USD42,017,000USD
    Minority Interest———————0USD
    Discontinued Operations———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,863,620,000USD2,719,284,000USD2,685,922,000USD2,630,998,000USD2,586,045,000USD2,467,973,000USD2,418,603,000USD2,378,084,000USD
    Cash And Equivalents448,699,000USD———————
    Total Current Assets1,112,238,000USD1,101,774,000USD1,040,154,000USD985,533,000USD923,072,000USD958,635,000USD923,774,000USD1,078,317,000USD
    Other Current Assets33,496,000USD32,138,000USD34,334,000USD35,020,000USD31,651,000USD28,424,000USD31,830,000USD31,321,000USD
    Other Non Current Assets71,859,000USD———————
    Total Liabilities1,183,816,000USD———————
    Total Current Liabilities264,933,000USD216,874,000USD239,764,000USD230,475,000USD225,572,000USD196,823,000USD216,402,000USD201,079,000USD
    Other Current Liabilities172,185,000USD———————
    Other Non Current Liabilities47,087,000USD———————
    Total Stockholder Equity1,679,804,000USD1,626,728,000USD1,584,303,000USD1,529,408,000USD1,488,048,000USD1,428,423,000USD1,379,359,000USD1,323,406,000USD
    Total Equity Including Noncontrolling Interest1,679,804,000USD———————
    Long Term Debt736,258,000USD735,160,000USD734,038,000USD732,916,000USD731,795,000USD730,673,000USD729,551,000USD750,505,000USD
    Deferred Revenue Non Current1,347,000USD———————
    Net Receivables224,237,000USD227,001,000USD223,611,000USD231,506,000USD224,239,000USD216,746,000USD209,166,000USD213,341,000USD
    Inventory374,112,000USD352,386,000USD333,705,000USD326,550,000USD323,309,000USD317,936,000USD306,063,000USD310,527,000USD
    Property Plant Equipment Net520,525,000USD520,333,000USD516,001,000USD506,500,000USD499,264,000USD478,046,000USD451,673,000USD458,520,000USD
    Goodwill539,772,000USD———————
    Accounts Payable70,737,000USD67,853,000USD60,551,000USD64,746,000USD69,066,000USD63,759,000USD68,502,000USD60,808,000USD
    Short Term Debt10,921,000USD11,228,000USD10,876,000USD10,612,000USD10,262,000USD9,435,000USD10,331,000USD11,469,000USD
    Common Stock783,892,000USD769,271,000USD763,909,000USD747,103,000USD734,841,000USD718,111,000USD703,219,000USD669,207,000USD
    Retained Earnings903,828,000USD865,025,000USD824,030,000USD786,024,000USD758,269,000USD725,688,000USD695,541,000USD667,594,000USD
    Accumulated Other Comprehensive Income-7,916,000USD-7,568,000USD-3,636,000USD-3,719,000USD-5,062,000USD-15,376,000USD-19,401,000USD-13,395,000USD
    Intangible Assets—511,995,000USD537,654,000USD538,400,000USD562,158,000USD478,976,000USD498,265,000USD372,164,000USD
    Total Liab—1,092,556,000USD1,101,619,000USD1,101,590,000USD1,097,997,000USD1,039,550,000USD1,039,244,000USD1,054,678,000USD
    Other Current Liab—132,760,000USD163,396,000USD147,377,000USD140,204,000USD118,679,000USD134,077,000USD127,255,000USD
    Capital Stock—769,271,000USD763,909,000USD747,103,000USD734,841,000USD718,111,000USD703,219,000USD669,207,000USD
    Good Will—503,432,000USD506,837,000USD507,427,000USD504,555,000USD464,360,000USD463,511,000USD399,448,000USD
    Cash—490,249,000USD448,504,000USD392,457,000USD343,873,000USD395,529,000USD376,715,000USD523,128,000USD
    Cash And Short Term Investments—490,249,000USD448,504,000USD392,457,000USD343,873,000USD395,529,000USD376,715,000USD523,128,000USD
    Net Debt—331,314,000USD449,726,000USD428,695,000USD476,680,000USD422,128,000USD417,950,000USD296,024,000USD
    Short Long Term Debt Total—821,563,000USD898,230,000USD821,152,000USD820,553,000USD817,657,000USD794,665,000USD819,152,000USD
    Property Plant Equipment Gross—903,006,000USD892,446,000USD884,250,000USD870,971,000USD839,455,000USD803,278,000USD814,382,000USD
    Common Stock Shares Outstanding—60,013,000shares60,026,000shares59,919,000shares60,611,000shares61,278,000shares60,613,000shares59,537,000shares
    Non Current Assets Total—1,617,510,000USD1,645,768,000USD1,645,465,000USD1,662,973,000USD1,509,338,000USD1,494,829,000USD1,299,767,000USD
    Non Current Liabilities Total—875,682,000USD861,854,999USD871,115,000USD872,425,000USD842,727,000USD822,842,000USD853,599,000USD
    Non Current Liabilities Other—26,937,000USD12,554,000USD15,361,000USD13,959,000USD14,165,000USD17,569,000USD19,253,000USD
    Non Currrent Assets Other—24,109,000USD32,569,000USD76,854,000USD32,954,000USD31,930,000USD42,504,000USD62,382,000USD
    Net Working Capital—884,900,000USD800,390,000USD755,058,000USD697,500,000USD761,812,000USD707,372,000USD877,238,000USD
    Unclassified Non Current Assets—57,641,000USD23,964,000USD—64,042,000USD56,026,000USD16,044,000USD—
    Unclassified Current Liabilities—5,033,000USD4,941,000USD7,740,000USD6,040,000USD4,950,000USD3,492,000USD—
    Unclassified Non Current Liabilities—113,585,000USD115,262,999USD122,838,000USD126,671,000USD97,889,000USD75,722,000USD83,841,000USD
    Unclassified Equity—-769,271,000USD-763,909,000USD-747,103,000USD-734,841,000USD-718,111,000USD-703,219,000USD-669,207,000USD
    Long Term Investments——28,743,000USD———22,832,000USD—
    Other Assets———————1USD
    Current Deferred Revenue———————-60,808,000USD
    Short Term Investments———————2,149,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,685,922,000USD2,418,603,000USD2,325,244,000USD1,663,966,000USD1,648,294,000USD1,664,396,000USD1,757,321,000USD1,620,012,000USD
    Intangible Assets537,654,000USD498,265,000USD325,883,000USD275,872,000USD319,269,000USD367,915,000USD445,312,000USD462,713,000USD
    Other Current Assets34,334,000USD31,830,000USD26,202,000USD26,237,000USD19,699,000USD16,808,000USD15,988,000USD14,953,000USD
    Total Liab1,101,619,000USD1,039,244,000USD1,123,244,000USD519,569,000USD608,495,000USD705,821,000USD807,377,000USD687,237,000USD
    Total Stockholder Equity1,584,303,000USD1,379,359,000USD1,202,000,000USD1,144,397,000USD1,039,799,000USD958,575,000USD949,944,000USD932,775,000USD
    Other Current Liab163,396,000USD134,077,000USD120,447,000USD112,184,000USD148,346,000USD99,041,000USD93,634,000USD96,173,000USD
    Common Stock763,909,000USD703,219,000USD638,150,000USD675,174,000USD641,533,000USD606,224,000USD587,017,000USD571,383,000USD
    Capital Stock763,909,000USD703,219,000USD638,150,000USD675,174,000USD641,533,000USD606,224,000USD587,017,000USD571,383,000USD
    Retained Earnings824,030,000USD695,541,000USD575,184,000USD480,773,000USD406,257,000USD357,803,000USD368,221,000USD363,425,000USD
    Good Will506,837,000USD463,511,000USD382,240,000USD359,821,000USD361,741,000USD363,533,000USD353,193,000USD335,433,000USD
    Cash448,504,000USD376,715,000USD587,036,000USD58,408,000USD67,750,000USD56,916,000USD44,320,000USD67,359,000USD
    Cash And Short Term Investments448,504,000USD376,715,000USD589,136,000USD58,408,000USD67,750,000USD56,916,000USD44,320,000USD67,359,000USD
    Total Current Assets1,040,154,000USD923,774,000USD1,108,470,000USD529,084,000USD482,212,000USD429,707,000USD454,538,000USD429,834,000USD
    Total Current Liabilities239,764,000USD216,402,000USD203,564,000USD220,645,000USD236,280,000USD185,004,000USD181,656,000USD175,343,000USD
    Net Debt449,726,000USD417,950,000USD304,323,000USD221,347,000USD257,947,000USD391,053,000USD490,978,000USD327,793,000USD
    Short Term Debt10,876,000USD10,331,000USD12,087,000USD33,260,000USD29,774,000USD33,306,000USD30,600,000USD22,000,000USD
    Short Long Term Debt Total898,230,000USD794,665,000USD891,359,000USD279,755,000USD325,697,000USD447,969,000USD535,298,000USD395,152,000USD
    Long Term Debt734,038,000USD729,551,000USD823,013,000USD186,759,000USD234,397,000USD343,722,000USD431,984,000USD373,152,000USD
    Long Term Investments28,743,000USD22,832,000USD19,061,000USD15,576,000USD14,711,000USD12,043,000USD17,129,000USD28,302,000USD
    Net Receivables223,611,000USD209,166,000USD189,261,000USD178,448,000USD172,841,000USD157,964,000USD168,532,000USD149,986,000USD
    Inventory333,705,000USD306,063,000USD303,871,000USD265,991,000USD221,922,000USD198,019,000USD225,698,000USD197,536,000USD
    Accounts Payable60,551,000USD68,502,000USD65,944,000USD68,504,000USD55,624,000USD49,837,000USD54,623,000USD54,024,000USD
    Property Plant Equipment Net516,001,000USD451,673,000USD446,570,000USD448,238,000USD437,571,000USD460,968,000USD459,029,000USD331,452,000USD
    Property Plant Equipment Gross892,446,000USD803,278,000USD775,606,000USD686,247,000USD652,276,000USD460,968,000USD459,029,000USD331,452,000USD
    Accumulated Other Comprehensive Income-3,636,000USD-19,401,000USD-11,334,000USD-11,550,000USD-7,991,000USD-5,452,000USD-5,294,000USD-2,033,000USD
    Common Stock Shares Outstanding60,460,000shares59,365,000shares58,356,000shares57,671,000shares57,359,000shares55,434,000shares56,235,000shares53,931,000shares
    Non Current Assets Total1,645,768,000USD1,494,829,000USD1,216,774,000USD1,134,882,000USD1,166,082,000USD1,234,689,000USD1,302,783,000USD1,190,178,000USD
    Non Current Liabilities Total861,854,999USD822,842,000USD919,680,000USD298,924,000USD372,215,000USD520,817,000USD625,721,000USD511,894,000USD
    Non Current Liabilities Other12,554,000USD17,569,000USD15,742,000USD16,648,000USD24,516,000USD126,975,000USD58,463,000USD71,160,000USD
    Non Currrent Assets Other32,569,000USD42,504,000USD35,732,000USD28,776,000USD26,710,000USD25,633,000USD24,332,000USD51,656,000USD
    Net Working Capital800,390,000USD707,372,000USD904,906,000USD308,439,000USD245,932,000USD244,703,000USD272,882,000USD254,491,000USD
    Unclassified Non Current Assets23,964,000USD-22,832,000USD—-25,332,000USD-41,421,000USD-223,112,000USD-24,332,000USD-51,656,000USD
    Unclassified Current Liabilities4,941,000USD3,492,000USD—-4,553,000USD-5,902,000USD-9,277,000USD-4,701,000USD-18,854,000USD
    Unclassified Non Current Liabilities115,262,999USD75,722,000USD80,925,000USD9,362,000USD-12,604,000USD-102,692,000USD14,541,000USD-138,742,000USD
    Unclassified Equity-763,909,000USD-703,219,000USD-638,150,000USD-675,174,000USD-641,533,000USD-606,224,000USD-587,017,000USD-571,383,000USD
    Other Assets—38,876,000USD—31,931,000USD47,501,000USD227,709,000USD28,120,000USD32,278,000USD
    Current Deferred Revenue——5,086,000USD——4,597,000USD——
    Short Term Investments——2,100,000USD————0USD
    Deferred Long Term Liab———33,726,000USD49,614,000USD50,120,000USD—67,582,000USD
    Other Liab———52,429,000USD76,292,000USD102,692,000USD120,733,000USD138,742,000USD
    Short Long Term Debt———11,250,000USD8,438,000USD7,500,000USD7,500,000USD22,000,000USD
    Accumulated Depreciation———-303,271,000USD-280,618,000USD-260,719,000USD—-209,563,000USD
    Net Tangible Assets———508,704,000USD358,789,000USD227,127,000USD151,439,000USD134,629,000USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation61,538,000USD
    Stock Based Compensation21,876,000USD
    Change To Account Receivables-21,328,000USD
    Change To Inventory-43,579,000USD
    Change To Liabilities9,160,000USD
    Change In Working Capital-51,799,000USD
    Operating Cash Flow109,957,000USD
    Capital Expenditures-33,340,000USD
    Other Investing Activities-92,997,000USD
    Unclassified Investing Cash Flow23,938,000USD
    Investing Cash Flow-102,399,000USD
    Financing Cash Flow-5,341,000USD
    Effect Of Forex Changes On Cash140,000USD
    Change In Cash2,357,000USD
    End Cash Flow450,906,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income40,995,000USD38,006,000USD27,755,000USD32,581,000USD30,147,000USD27,947,000USD28,444,000USD35,726,000USD
    Depreciation33,350,000USD34,327,000USD34,243,000USD33,803,000USD32,276,000USD31,596,000USD29,383,000USD27,032,000USD
    Stock Based Compensation8,961,000USD9,897,000USD13,612,000USD10,873,000USD9,078,000USD9,515,000USD6,713,000USD7,011,000USD
    Other Non Cash Items-10,558,000USD3,091,000USD1,722,000USD1,560,000USD2,530,000USD-11,080,000USD1,812,000USD1,879,000USD
    Change To Account Receivables-1,322,000USD8,953,000USD-3,534,000USD-2,445,000USD-5,701,000USD36,000USD-10,719,000USD-6,439,000USD
    Change To Inventory-22,655,000USD-6,529,000USD-3,353,000USD-1,121,000USD-10,599,000USD557,000USD-5,963,000USD3,501,000USD
    Change In Working Capital-32,067,000USD7,975,000USD-2,350,000USD4,490,000USD-33,459,000USD10,766,000USD-19,019,000USD-3,142,000USD
    Total Cash From Operating Activities40,681,000USD98,510,000USD74,982,000USD83,307,000USD40,572,000USD68,744,000USD47,333,000USD68,506,000USD
    Capital Expenditures-16,009,000USD-21,518,000USD-23,471,000USD21,518,000USD-21,518,000USD-4,237,000USD-9,921,000USD-11,342,000USD
    Free Cash Flow24,672,000USD76,992,000USD51,511,000USD104,825,000USD19,054,000USD64,507,000USD37,412,000USD57,164,000USD
    Total Cashflows From Investing Activities7,734,000USD-50,335,000USD-24,065,000USD-143,351,000USD-29,635,000USD-214,447,000USD-115,668,000USD-16,487,000USD
    Total Cash From Financing Activities-6,289,000USD5,062,000USD-365,000USD4,347,000USD6,955,000USD2,432,000USD-47,574,000USD3,137,000USD
    Issuance Of Capital Stock2,775,000USD6,034,000USD2,165,000USD6,862,000USD13,152,000USD25,484,000USD4,493,000USD3,201,000USD
    Change In Cash41,700,000USD53,988,000USD50,646,000USD-53,680,000USD18,828,000USD-146,510,000USD-113,435,000USD54,725,000USD
    Begin Period Cash Flow448,549,000USD394,561,000USD343,915,000USD397,595,000USD378,767,000USD525,277,000USD638,712,000USD583,987,000USD
    End Period Cash Flow490,249,000USD448,549,000USD394,561,000USD343,915,000USD397,595,000USD378,767,000USD525,277,000USD638,712,000USD
    Other Cashflows From Investing Activities8,734,000USD-6,882,000USD-315,000USD-43,314,000USD-7,117,000USD-3,771,000USD-497,000USD2,000USD
    Other Cashflows From Financing Activities-9,064,000USD-972,000USD-2,530,000USD-2,515,000USD-6,197,000USD-52,000USD-67,000USD-64,000USD
    Unclassified Investing Cash Flow15,009,000USD-21,935,000USD23,786,000USD21,796,000USD28,635,000USD8,008,000USD10,418,000USD11,340,000USD
    Net Borrowings—0USD0USD0USD0USD-23,000,000USD-52,000,000USD—
    Unclassified Operating Cash Flow—5,214,000USD——————
    Investments——-24,065,000USD-143,351,000USD-29,635,000USD-214,447,000USD-115,668,000USD-16,487,000USD
    Sale Purchase Of Stock——————1,592,000USD—
    Unclassified Financing Cash Flow——————2,901,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income128,489,000USD120,357,000USD94,411,000USD74,516,000USD48,454,000USD-9,843,000USD5,451,000USD42,017,000USD
    Depreciation134,649,000USD114,732,000USD101,292,000USD92,198,000USD95,784,000USD106,816,000USD104,356,000USD69,546,000USD
    Stock Based Compensation43,460,000USD28,473,000USD21,333,000USD18,042,000USD16,090,000USD14,339,000USD9,382,000USD6,117,000USD
    Other Non Cash Items8,903,000USD9,055,000USD10,780,000USD15,857,000USD9,372,000USD31,015,000USD26,785,000USD2,745,000USD
    Change To Account Receivables-2,727,000USD-21,704,000USD-9,545,000USD-15,116,000USD-8,618,000USD10,425,000USD-17,900,000USD-27,522,000USD
    Change To Inventory-21,602,000USD-2,287,000USD-32,105,000USD-47,929,000USD-25,183,000USD29,429,000USD-27,044,000USD-28,172,000USD
    Change In Working Capital-23,344,000USD-36,945,000USD-70,022,000USD-71,398,000USD-17,838,000USD34,238,000USD-55,725,000USD-35,944,000USD
    Total Cash From Operating Activities297,371,000USD220,799,000USD145,151,000USD114,291,000USD147,231,000USD165,270,000USD77,813,000USD86,533,000USD
    Capital Expenditures-84,836,000USD-38,043,000USD-36,701,000USD-45,029,000USD-27,939,000USD-49,276,000USD-81,497,000USD-66,336,000USD
    Free Cash Flow212,535,000USD182,756,000USD108,450,000USD69,262,000USD119,292,000USD115,994,000USD-3,684,000USD20,197,000USD
    Total Cashflows From Investing Activities-247,386,000USD-368,653,000USD-175,347,000USD-57,397,000USD-37,161,000USD-58,652,000USD-134,481,000USD-378,820,000USD
    Net Borrowings0USD-99,063,000USD619,579,000USD-44,938,000USD-108,500,000USD-88,375,000USD44,500,000USD116,500,000USD
    Total Cash From Financing Activities15,999,000USD-60,008,000USD559,266,000USD-60,260,000USD-98,435,000USD-95,706,000USD33,533,000USD328,280,000USD
    Issuance Of Capital Stock28,213,000USD40,908,000USD24,783,000USD20,070,000USD21,306,000USD6,635,000USD6,252,000USD214,993,000USD
    Change In Cash69,782,000USD-210,377,000USD528,586,000USD-7,192,000USD10,834,000USD12,596,000USD-23,039,000USD35,023,000USD
    Begin Period Cash Flow378,767,000USD589,144,000USD60,558,000USD67,750,000USD56,916,000USD44,320,000USD67,359,000USD32,336,000USD
    End Period Cash Flow448,549,000USD378,767,000USD589,144,000USD60,558,000USD67,750,000USD56,916,000USD44,320,000USD67,359,000USD
    Other Cashflows From Investing Activities-17,781,000USD-10,428,000USD-799,000USD-4,081,000USD-2,051,000USD292,000USD920,000USD-10,695,000USD
    Other Cashflows From Financing Activities-12,214,000USD-1,853,000USD-75,897,000USD-35,392,000USD-11,241,000USD-13,966,000USD-17,219,000USD-3,213,000USD
    Unclassified Operating Cash Flow5,214,000USD-14,873,000USD-12,643,000USD-14,924,000USD-4,631,000USD-11,295,000USD-12,436,000USD2,052,000USD
    Unclassified Investing Cash Flow-144,769,000USD48,471,000USD46,486,000USD49,110,000USD29,990,000USD-9,918,000USD80,577,000USD-291,039,000USD
    Investments—-368,653,000USD-184,333,000USD-57,397,000USD-37,161,000USD250,000USD-134,481,000USD-10,750,000USD
    Sale Purchase Of Stock——-5,123,000USD-2,474,000USD-576,000USD-866,000USD6,252,000USD-2,616,000USD
    Unclassified Financing Cash Flow——20,707,000USD25,018,000USD22,458,000USD8,367,000USD—217,609,000USD
    Change To Liabilities———12,661,000USD6,050,000USD333,000USD-2,295,000USD15,726,000USD
    Dividends Paid———-2,474,000USD-576,000USD-866,000USD—0USD
    Cash And Cash Equivalents Changes———-3,366,000USD11,635,000USD10,912,000USD—35,023,000USD
    Exchange Rate Changes———————-970,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational166,792,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States252,051,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFoundational — Product And Service Other1,236,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFoundational Access161,786,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFoundational Original Equipment Manufacturer48,338,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFoundational Procedural Solutions27,949,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductFoundational Vascular Intervention41,652,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Cardiac Therapies28,510,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Endoscopy23,647,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Oncology25,774,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Original Equipment Manufacturer12,797,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Renal Therapies12,713,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTherapeutic Vascular Intervention34,441,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational155,361,000USD0000856982-26-000025
    Q1 2026Quarterly · 2026-03-31GeographyUnited States226,516,000USD0000856982-26-000025
    Q1 2026Quarterly · 2026-03-31ProductFoundational255,479,000USD0000856982-26-000025
    Q1 2026Quarterly · 2026-03-31ProductTherapeutic126,398,000USD0000856982-26-000025
    Q4 2025Quarterly · 2025-12-31GeographyInternational155,673,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States238,223,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational606,400,000USD0000856982-26-000008
    FY 2025Yearly · 2025-12-31GeographyUnited States909,466,000USD0000856982-26-000008
    FY 2025Yearly · 2025-12-31SegmentCardiovascular1,443,042,000USD0000856982-26-000008
    FY 2025Yearly · 2025-12-31SegmentEndoscopy72,864,000USD0000856982-26-000008
    Q4 2025Quarterly · 2025-12-31SegmentCardiovascular373,879,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentEndoscopy20,057,000USDLegacy provider
    Q3 2025Quarterly · 2025-09-30GeographyInternational153,560,000USD0000856982-25-000056
    Q3 2025Quarterly · 2025-09-30GeographyUnited States230,597,000USD0000856982-25-000056
    Q3 2025Quarterly · 2025-09-30SegmentCardiovascular366,425,000USD0000856982-25-000056
    Q3 2025Quarterly · 2025-09-30SegmentEndoscopy17,732,000USD0000856982-25-000056
    Q2 2025Quarterly · 2025-06-30GeographyInternational155,380,000USD0000856982-25-000046
    Q2 2025Quarterly · 2025-06-30GeographyUnited States227,082,000USD0000856982-25-000046
    Q2 2025Quarterly · 2025-06-30SegmentCardiovascular364,025,000USD0000856982-25-000046
    Q2 2025Quarterly · 2025-06-30SegmentEndoscopy18,437,000USD0000856982-25-000046
    Q1 2025Quarterly · 2025-03-31GeographyInternational141,787,000USD0000856982-26-000025
    Q1 2025Quarterly · 2025-03-31GeographyUnited States213,564,000USD0000856982-26-000025
    Q1 2025Quarterly · 2025-03-31ProductFoundational240,382,000USD0000856982-26-000025
    Q1 2025Quarterly · 2025-03-31ProductTherapeutic114,969,000USD0000856982-26-000025
    Q1 2025Quarterly · 2025-03-31SegmentCardiovascular338,713,000USD0000856982-25-000027
    Q1 2025Quarterly · 2025-03-31SegmentEndoscopy16,638,000USD0000856982-25-000027
    Q4 2024Quarterly · 2024-12-31GeographyInternational141,594,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States213,530,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational555,700,000USD0000856982-26-000008
    FY 2024Yearly · 2024-12-31GeographyUnited States800,780,000USD0000856982-26-000008
    FY 2024Yearly · 2024-12-31SegmentCardiovascular1,301,744,000USD0000856982-26-000008
    FY 2024Yearly · 2024-12-31SegmentEndoscopy54,770,000USD0000856982-26-000008
    Q4 2024Quarterly · 2024-12-31SegmentCardiovascular337,700,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentEndoscopy17,458,000USDLegacy provider
    Q3 2024Quarterly · 2024-09-30GeographyInternational133,353,000USD0000856982-25-000056
    Q3 2024Quarterly · 2024-09-30GeographyUnited States206,492,000USD0000856982-25-000056
    Q3 2024Quarterly · 2024-09-30SegmentCardiovascular322,855,000USD0000856982-25-000056
    Q3 2024Quarterly · 2024-09-30SegmentEndoscopy16,990,000USD0000856982-25-000056
    Q2 2024Quarterly · 2024-06-30SegmentCardiovascular327,815,000USD0000856982-25-000046
    Q2 2024Quarterly · 2024-06-30SegmentEndoscopy10,188,000USD0000856982-25-000046
    Q1 2024Quarterly · 2024-03-31SegmentCardiovascular313,374,000USD0000856982-25-000027
    Q1 2024Quarterly · 2024-03-31SegmentEndoscopy10,134,000USD0000856982-25-000027
    FY 2023Yearly · 2023-12-31GeographyInternational530,400,000USD0000856982-26-000008
    FY 2023Yearly · 2023-12-31GeographyUnited States726,989,000USD0000856982-26-000008
    FY 2023Yearly · 2023-12-31SegmentCardiovascular1,220,560,000USD0000856982-26-000008
    FY 2023Yearly · 2023-12-31SegmentEndoscopy36,806,000USD0000856982-26-000008
    FY 2022Yearly · 2022-12-31SegmentCardiovascular1,118,224,000USD0000856982-25-000011
    FY 2022Yearly · 2022-12-31SegmentEndoscopy32,757,000USD0000856982-25-000011
    FY 2021Yearly · 2021-12-31SegmentCardiovascular1,043,227,000USD0000856982-24-000015
    FY 2021Yearly · 2021-12-31SegmentEndoscopy31,524,000USD0000856982-24-000015
    FY 2020Yearly · 2020-12-31SegmentCardiovascular934,202,000USD0000856982-23-000011
    FY 2020Yearly · 2020-12-31SegmentEndoscopy29,673,000USD0000856982-23-000011
    FY 2019Yearly · 2019-12-31SegmentCardiovascular960,981,000USD0000856982-22-000013
    FY 2019Yearly · 2019-12-31SegmentEndoscopy33,871,000USD0000856982-22-000013
    FY 2018Yearly · 2018-12-31GeographyInternational386,300,000USD0000856982-19-000016
    FY 2018Yearly · 2018-12-31GeographyUnited States496,413,000USD0000856982-19-000016
    FY 2018Yearly · 2018-12-31SegmentCardiovascular849,477,000USD0000856982-21-000003
    FY 2018Yearly · 2018-12-31SegmentEndoscopy33,276,000USD0000856982-21-000003
    FY 2017Yearly · 2017-12-31GeographyInternational307,100,000USD0000856982-19-000016
    FY 2017Yearly · 2017-12-31GeographyUnited States420,703,000USD0000856982-19-000016
    FY 2016Yearly · 2016-12-31GeographyInternational233,500,000USD0000856982-19-000016
    FY 2016Yearly · 2016-12-31GeographyUnited States370,350,000USD0000856982-19-000016
    FY 2011Yearly · 2011-12-31ProductCatheters55,357,000USD0000856982-12-000012
    FY 2011Yearly · 2011-12-31ProductCustom Kit And Procedures Trays91,532,000USD0000856982-12-000012
    FY 2011Yearly · 2011-12-31ProductEmbolization Devices31,229,000USD0000856982-12-000012
    FY 2011Yearly · 2011-12-31ProductEndoscopy Devices12,019,000USD0000856982-12-000012
    FY 2011Yearly · 2011-12-31ProductInflation Devices67,353,000USD0000856982-12-000012
    FY 2011Yearly · 2011-12-31ProductStand Alone Devices101,959,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductCatheters44,824,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductCustom Kit And Procedures Trays82,799,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductEmbolization Devices9,003,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductEndoscopy Devices9,048,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductInflation Devices62,495,000USD0000856982-12-000012
    FY 2010Yearly · 2010-12-31ProductStand Alone Devices88,586,000USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductCatheters38,126,000USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductCustom Kit And Procedures Trays74,541,000USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductEmbolization Devices0USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductEndoscopy Devices7,662,000USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductInflation Devices61,058,000USD0000856982-12-000012
    FY 2009Yearly · 2009-12-31ProductStand Alone Devices76,075,000USD0000856982-12-000012

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.